Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review
Tumor-associated macrophage (TAM) phagocytic activity is emerging as a new mechanism to harness for cancer treatment. Currently, many approaches are investigated at the preclinical level and some modalities have now reached clinical trials, including the targeting of the phagocytosis inhibitor CD47....
Saved in:
| Main Authors: | Marc Lecoultre, Valérie Dutoit, Paul R Walker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/2/e001408.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Commentary on “Targeted release of a bispecific fusion protein SIRPα/Siglec-10 by oncolytic adenovirus reinvigorates tumor-associated macrophages to improve therapeutic outcomes in solid tumors”
by: Marc Lecoultre, et al.
Published: (2025-06-01) -
Macrophages and tumor progression: on the way to macrophage-specific therapy
by: N. V. Cherdyntseva, et al.
Published: (2018-01-01) -
EXPRESSION of MACROPHAGe-ASSOCIATED GENES IN BREAST TUMORS: RELATION TO TUMOR PROGRESSION
by: N. V. Litviakov, et al.
Published: (2017-12-01) -
Tumor-Associated Macrophages as Key Modulators of Disease Progression in Diffuse Large B-Cell Lymphoma
by: Corina Joldes, et al.
Published: (2025-05-01) -
Gingipains protect Porphyromonas gingivalis from macrophage-mediated phagocytic clearance.
by: Magdalena Widziolek, et al.
Published: (2025-01-01)